BE552153A - - Google Patents
Info
- Publication number
- BE552153A BE552153A BE552153DA BE552153A BE 552153 A BE552153 A BE 552153A BE 552153D A BE552153D A BE 552153DA BE 552153 A BE552153 A BE 552153A
- Authority
- BE
- Belgium
- Prior art keywords
- acetate
- chloro
- activity
- 17alpha
- epoxy
- Prior art date
Links
- QTBSBXVTEAMEQO-UHFFFAOYSA-M acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 claims description 9
- 230000001195 anabolic Effects 0.000 claims description 6
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 6
- 150000001875 compounds Chemical class 0.000 claims description 4
- 235000019441 ethanol Nutrition 0.000 claims description 4
- 238000000034 method Methods 0.000 claims description 4
- 230000001548 androgenic Effects 0.000 claims description 3
- 239000002253 acid Substances 0.000 claims description 2
- 229910052500 inorganic mineral Inorganic materials 0.000 claims description 2
- 239000011707 mineral Substances 0.000 claims description 2
- 239000003960 organic solvent Substances 0.000 claims description 2
- 238000002360 preparation method Methods 0.000 claims description 2
- 150000003431 steroids Chemical class 0.000 claims 2
- 125000002252 acyl group Chemical group 0.000 claims 1
- 230000000875 corresponding Effects 0.000 claims 1
- QTBSBXVTEAMEQO-UHFFFAOYSA-N acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 7
- 239000000203 mixture Substances 0.000 description 7
- RTZKZFJDLAIYFH-UHFFFAOYSA-N diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 6
- OKKJLVBELUTLKV-UHFFFAOYSA-N methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 6
- HEMHJVSKTPXQMS-UHFFFAOYSA-M sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 6
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 5
- HEDRZPFGACZZDS-UHFFFAOYSA-N chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 4
- MRKZAZMYXYSBDG-UHFFFAOYSA-N cyclopentyl propanoate Chemical compound CCC(=O)OC1CCCC1 MRKZAZMYXYSBDG-UHFFFAOYSA-N 0.000 description 4
- 239000004593 Epoxy Substances 0.000 description 3
- XEKOWRVHYACXOJ-UHFFFAOYSA-N acetic acid ethyl ester Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 3
- -1 epoxy acetates Chemical class 0.000 description 3
- MHAJPDPJQMAIIY-UHFFFAOYSA-N hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 description 3
- REWKEGSQGOSEES-FNKXXKKYSA-N 17β-Hydroxyestr-4-en-3-one cyclopentanepropionate Chemical compound O([C@H]1CC[C@H]2[C@H]3[C@@H]([C@H]4CCC(=O)C=C4CC3)CC[C@@]21C)C(=O)CCC1CCCC1 REWKEGSQGOSEES-FNKXXKKYSA-N 0.000 description 2
- KRHYYFGTRYWZRS-UHFFFAOYSA-N HF Chemical compound F KRHYYFGTRYWZRS-UHFFFAOYSA-N 0.000 description 2
- 210000003205 Muscles Anatomy 0.000 description 2
- NPAGDVCDWIYMMC-IZPLOLCNSA-N Nandrolone Chemical compound O=C1CC[C@@H]2[C@H]3CC[C@](C)([C@H](CC4)O)[C@@H]4[C@@H]3CCC2=C1 NPAGDVCDWIYMMC-IZPLOLCNSA-N 0.000 description 2
- WFDIJRYMOXRFFG-UHFFFAOYSA-N acetic anhydride Chemical compound CC(=O)OC(C)=O WFDIJRYMOXRFFG-UHFFFAOYSA-N 0.000 description 2
- UHOVQNZJYSORNB-UHFFFAOYSA-N benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 2
- 238000002844 melting Methods 0.000 description 2
- 229960004719 nandrolone Drugs 0.000 description 2
- 239000003208 petroleum Substances 0.000 description 2
- JUJWROOIHBZHMG-UHFFFAOYSA-N pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 2
- 125000002599 19-nortestosterone group Chemical group 0.000 description 1
- 241000065675 Cyclops Species 0.000 description 1
- 206010053759 Growth retardation Diseases 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-N HCl Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 1
- ZXSWTMLNIIZPET-ZOFHRBRSSA-N Methylestrenolone Chemical compound C1CC2=CC(=O)CC[C@@H]2[C@@H]2[C@@H]1[C@@H]1CC[C@](C)(O)[C@@]1(C)CC2 ZXSWTMLNIIZPET-ZOFHRBRSSA-N 0.000 description 1
- OZDDFAQVVGFDJP-YGRHGMIBSA-N Norclostebol Chemical compound O=C1CC[C@@H]2[C@H]3CC[C@](C)([C@H](CC4)O)[C@@H]4[C@@H]3CCC2=C1Cl OZDDFAQVVGFDJP-YGRHGMIBSA-N 0.000 description 1
- 208000001132 Osteoporosis Diseases 0.000 description 1
- 210000002307 Prostate Anatomy 0.000 description 1
- 241000700159 Rattus Species 0.000 description 1
- 210000001625 Seminal Vesicles Anatomy 0.000 description 1
- 206010039966 Senile dementia Diseases 0.000 description 1
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 1
- ASCUXPQGEXGEMJ-GPLGTHOPSA-N [(2R,3S,4S,5R,6S)-3,4,5-triacetyloxy-6-[[(2R,3R,4S,5R,6R)-3,4,5-triacetyloxy-6-(4-methylanilino)oxan-2-yl]methoxy]oxan-2-yl]methyl acetate Chemical compound CC(=O)O[C@@H]1[C@@H](OC(C)=O)[C@@H](OC(C)=O)[C@@H](COC(=O)C)O[C@@H]1OC[C@@H]1[C@@H](OC(C)=O)[C@H](OC(C)=O)[C@@H](OC(C)=O)[C@H](NC=2C=CC(C)=CC=2)O1 ASCUXPQGEXGEMJ-GPLGTHOPSA-N 0.000 description 1
- FNMAFGQVNCRKGS-JZQWUOKRSA-N [(8R,9S,10R,13S,14S,17S)-4-chloro-13-methyl-3-oxo-2,6,7,8,9,10,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-17-yl] acetate Chemical compound C1CC2=C(Cl)C(=O)CC[C@@H]2[C@@H]2[C@@H]1[C@@H]1CC[C@H](OC(=O)C)[C@@]1(C)CC2 FNMAFGQVNCRKGS-JZQWUOKRSA-N 0.000 description 1
- 239000003513 alkali Substances 0.000 description 1
- UXTMROKLAAOEQO-UHFFFAOYSA-N chloroform;ethanol Chemical compound CCO.ClC(Cl)Cl UXTMROKLAAOEQO-UHFFFAOYSA-N 0.000 description 1
- 238000004821 distillation Methods 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 150000002118 epoxides Chemical class 0.000 description 1
- 230000004927 fusion Effects 0.000 description 1
- 231100000001 growth retardation Toxicity 0.000 description 1
- 229910000041 hydrogen chloride Inorganic materials 0.000 description 1
- 230000001665 lethal Effects 0.000 description 1
- 231100000518 lethal Toxicity 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 230000001568 sexual Effects 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 230000004936 stimulating Effects 0.000 description 1
- 235000011149 sulphuric acid Nutrition 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
Landscapes
- Steroid Compounds (AREA)
Publications (1)
Publication Number | Publication Date |
---|---|
BE552153A true BE552153A (fi) |
Family
ID=177438
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BE552153D BE552153A (fi) |
Country Status (1)
Country | Link |
---|---|
BE (1) | BE552153A (fi) |
-
0
- BE BE552153D patent/BE552153A/fr unknown
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BE552153A (fi) | ||
BE552152A (fi) | ||
EP0702025B1 (fr) | Procédé de préparation d'un dérivé stéroide 17bêta-carboxy et nouveaux intermédiaires | |
CH660741A5 (fr) | Procede de preparation d'un 16-imino 17-aza steroide eventuellement tritie et intermediaires de ce procede. | |
BE544381A (fi) | ||
BE818471A (fr) | Procede pour preparer des 1-aralkyl-4-amino-methylpiperidine-4-ols | |
CH395067A (fr) | Procédé de préparation de nouveaux dérivés du cyclopentanonaphtalène | |
BE503510A (fi) | ||
BE460230A (fi) | ||
CH426858A (fr) | Procédé de préparation de nouveaux dérivés colchiciques | |
BE632687A (fi) | ||
CH368164A (fr) | Procédé pour la préparation de dérivés de l'étiocholane | |
CH428724A (fr) | Procédé de préparation de la 6,17a-diméthyl-4,6-pregnadiène-3,20-dione | |
BE556145A (fi) | ||
BE544240A (fi) | ||
BE557735A (fi) | ||
CH511253A (fr) | Procédé de préparation de nouveaux dérivés 2-oxa-stéroïdes insaturés | |
BE567724A (fi) | ||
BE515630A (fi) | ||
BE519868A (fi) | ||
BE688477A (fi) | ||
CH302796A (fr) | Procédé de préparation du pseudo-1-p-nitrophényl-2-acétamido-propanediol-1,3. | |
BE620548A (fi) | ||
BE552150A (fi) | ||
BE550147A (fi) |